Skip to main content
. Author manuscript; available in PMC: 2014 Sep 27.
Published in final edited form as: Biol Psychiatry. 2013 Mar 27;77(2):196–202. doi: 10.1016/j.biopsych.2013.02.017

Table 1.

Participant Demographics

[11C]-(+)-PHNO (n = 26) [11C]-Raclopride (n = 35) [11C]-(+)-PHNO and [11C]-Raclopride (n = 15)
Age
 Mean (SD) 29.88 (7.43) 31.31a (9.02) 29.67 (6.81)
 Range 20–45 20–47 20–45
Sex
 M (F) 19 (7) 21b (14) 11 (4)
Body Mass Index
 Mean (SD) 23.66 (2.99) 23.24c (2.71) 23.32 (3.13)
 Range 18.61–27.77 18.61–27.83 18.61–27.77

Excluding the subjects scanned with both tracers (n = 15), the subjects scanned with [11C]-raclopride only (n = 20) did not differ from those scanned with [11C]-(+)-PHNO only (n = 11) in aage (p = .28), bsex (p = .46), or cbody mass index (p = .89).